Evercore ISI analyst Elizabeth Anderson initiated coverage of Hinge Health (HNGE) with an Outperform rating and $50 price target Hinge offers virtual physical therapy for musculoskeletal problems, broadening access to patients, the analyst tells investors in a research note. The firm says the company’s multi-condition offering has proven attractive to employers and health plans as it drives hard dollar cost savings through either an annual subscription or utilization-based model for $900 per year. Evercore believes Hinge has “multiple levers” to continue to grow 20% annually as it attracts new customers and increases penetration within existing ones.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HNGE:
- Hinge Health: A Compelling Buy with Innovative Digital Solutions and Favorable Valuation
- Hinge Health, Inc.: A Leader in Digital MSK Care with Strong Growth Potential and High ROI
- Hinge Health initiated with a Buy at Truist
- Hinge Health initiated with an Overweight at Morgan Stanley
- Hinge Health initiated with an Outperform at RBC Capital